Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.

Slides:

Advertisements

Similar presentations

Exercise And Statin – Associated Myopathy Paul D. Thompson, MD Director of Cardiology Henry Low Heart Center Hartford Hospital Hartford, CT.

Advertisements

Cholesterol Metabolism By Amr S. Moustafa, M.D.; Ph.D.

Drugs in dyslipidaemias

Cholesterol and Steroid Metabolism Dr. Nikhat Siddiqi1.

COMPOSITION OF LIPIDS Lipoproteins Apolipoproteins Lipoproteins Apolipoproteins Cholesterol Protein Triglyceride Phospholipid.

REGULATION OF ACETYL CoA PROCESSING BIOC 460 DR. TISCHLER LECTURE 37.

Cholesterol Metabolism

A New Statin Drug: A Brief History of My Career Bonny Ortolano, Ph.D. Genome Pharmaceuticals Cambridge, Massachusetts.

SECONDARY PREVENTIONS Jaimon Stucki MS-1 PSCOM. Blood Draw.

CHOLESTEROL 10/02-03/07 I.LEARNING OBJECTIVES 1) To identify the structure of cholesterol 2) To outline the synthesis of cholesterol 3) To describe the.

Cholesterol Metabolism Cardiovascular Block. Overview Introduction Cholesterol structure Cholesteryl esters Cholesterol synthesis Rate limiting step Regulation.

Hydroxymethylglutaryl-coenzyme A (HMG-CoA) is the precursor for cholesterol synthesis. HMG-CoA is also an intermediate on the pathway for synthesis of.

Part 5 Antiatheroscleotic drugs. §Plasma lipids § Cholesterol free cholesterol (FC) § cholesterolester (CE) § Triglyceride (TG) § Phospholipid (PL)

Cholesterol metabolism: INTRODUCTION  Cholesterol is a sterol, present in cell membrane, brain and lipoprotein  It is a precursor for all steroids 

Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.

MEDC 603 Fall Principles of Drug Design  Enzyme Inhibition Basics Example: 1) Statins (I) inhibit HMG CoA Reductase (E); S = HMG CoA; P = Mevalonate.

Lipid metabolism Chapter 26 Chem 454: Biochemistry II University of Wisconsin-Eau Claire Chapter 26 Chem 454: Biochemistry II University of Wisconsin-Eau.

Lipogenesis. Metabolism of cholesterol.

Cardiovascular Calcium Chanel Blockers Ace Inhibitors Anticoagulant/ Diuretics Lipid Lowering.

Cholesterol Metabolism.  The chemical and biochemical aspects of cholesterol regarding structure, distribution and biological functions in human body.

Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.

HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.

Atorvastatin Calcium Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of.

Loratadine Loratadine is a histamine H1 receptor antagonist, used to treat allergies. Also acts as a selective inhibitor of B(0)AT2 with IC50 of 4 μM.

Lipid metabolism and lung cancer

Nephritic and nephrotic syndromes

By: Dr Israa Omar MBBS, MRCP, MSc pharmacology

Cholesterol is a soft fatty substance that is produced in the body and also obtained from food substances such as dairy products, eggs (egg yolk is rich.

1. Abstract 3. Objective of the study 4. Methods 5. Results

Formative Test.

Metabolism of mevalonic acid and early steps in the biosynthesis of cholesterol. The structures and names of the intermediates in the synthetic pathway.

He is Dr. S C Khanna, a Consulting Physician at Tarapur Head Quarter.

Cholesterol Synthesis, Transport, & Excretion

Figure 6 Cholesterol metabolism in obesity-related glomerulopathy

Antilipidaemic agents

الاسبوع الإرشادي.

Figure 2 Hepatic action of functional foods and supplements

Cardiovascular System

Pseudopterosin Biosynthesis in Symbiodinium sp

Cholesterol synthesis

Bettina Haslinger-Löffler Kidney International

Statins and Glucose Metabolism: Are All Agents Alike?

Antilipemic Agents Lilley Pharmacology Text: Chapter 27

Chapter 27: Drugs for Lipid Disorders

Volume 11, Issue 1, Pages (January 2003)

Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia Carol K. Fosso, MDa,

Cholesterol and Steroid Metabolism

Committed step in cholesterol biosynthesis

Volume 74, Issue 5, Pages (September 2008)

Fig. 2 Paralog-selective inhibitors of GSK3α and GSK3β were designed and characterized. Paralog-selective inhibitors of GSK3α and GSK3β were designed and.

Effects of statins (hydroxymethylglutarate (HMG) coenzyme A reductase inhibitors) on synthesis of ubiquinone (coenzyme Q10, CoQ10). Effects of statins.

Current Evidence for Perioperative Statins in Cardiac Surgery

Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? Areef Ishani, Charles A. Herzog,

Volume 61, Issue 1, Pages (January 2002)

Statins and Glucose Metabolism: An Endocrinology Perspective

Volume 56, Pages S178-S181 (July 1999)

Gp78, a Membrane-Anchored Ubiquitin Ligase, Associates with Insig-1 and Couples Sterol-Regulated Ubiquitination to Degradation of HMG CoA Reductase Bao-Liang.

Statins Molecular mechanisms of action SREBP feedback control

Cholesterol Metabolism

Volume 11, Issue 4, Pages (October 2018)

Volume 56, Pages S28-S30 (July 1999)

Regulation of HMG-CoA Reductase As rate-limiting step, it is the principal site of regulation in cholesterol synthesis 1) Phosphorylation by cAMP-dependent.

Anti-inflammatory and immunomodulatory effects of statins

Effects of statins (hydroxymethylglutarate (HMG) coenzyme A reductase inhibitors) on synthesis of ubiquinone (coenzyme Q10, CoQ10). Effects of statins.

Olaf Schouten, MD, Jeroen J. Bax, MD, Martin Dunkelgrun, MD, Harm H

Fig. 2 Paralog-selective inhibitors of GSK3α and GSK3β were designed and characterized. Paralog-selective inhibitors of GSK3α and GSK3β were designed and.

Average warfarin dosage (mg/d) by CKD stages 1 and 2 (no/mild) versus stage 3 (moderate) versus stages 4 and 5 (severe) stratified by CYP2C9 and VKORC1.

Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells Donna H. Wong,

Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol Bao-Liang Song, Norman B. Javitt,

ATP III Guidelines Drug Therapy FUTURE RESEARCH.

Presentation transcript:

Pravastatin sodium Pravastatin sodium is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.